drugset / Trial / NCT00006213
BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
NaSingle-groupOpen-labelTreatment
Summary
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Phase I trial to study the effectiveness of BMS-214662 in treating patients who have acute leukemia, myelodysplastic syndrome, or chronic myeloid leukemia in blast phase
Timeline
- Start
- 2000-04
- Primary completion
- 2002-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-214662 | Small molecule | — | Intravenous |
Indications
acute promyelocytic leukemia
adult acute lymphoblastic leukemia
blast phase chronic myelogenous leukemia, BCR-ABL1 positive
childhood acute lymphoblastic leukemia
childhood acute myeloid leukemia
childhood myelodysplastic syndrome
myelodysplastic syndrome with excess blasts
refractory anemia with excess blasts in transformation